MYLOTARG (gemtuzumab ozogamicin) for injection, for intravenous use. Initial U.S. Approval: 2000

Categories: , .

MYLOTARG (gemtuzumab ozogamicin) for injection, for intravenous use. Initial U.S. Approval: 2000

INDICATIONS AND USAGE
MYLOTARG is a CD33-directed antibody-drug conjugate indicated for:
• treatment of newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults.
• treatment of relapsed or refractory CD33-positive AML in adults and in pediatric patients 2 years and older.
DOSAGE FORMS & STRENGTHS
For Injection: 4.5 mg as a lyophilized cake or powder in a single-dose vial for reconstitution and dilution.
Manufactured By: Pfizer Inc
Prescribing Information URL: Click Here

Access to MYLOTARG ™ (gemtuzumab ozogamicin) for injection: Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Gemtuzumab ozogamicin, sold under the brand name Mylotarg, is an antibody-drug conjugate (a drug-linked monoclonal antibody) that is used to treat acute myeloid leukemia.
In the United States, gemtuzumab ozogamicin is indicated for newly diagnosed CD33-positive acute myeloid leukemia (AML) for adults and children one month and older and for the treatment of relapsed or refractory CD33-positive AML in adults and children two years and older.

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.